Johnson & Johnson
Health & Medicine

Johnson & Johnson

0.0
0 ratings

American multinational pharmaceutical and medical device company

Multinational medical devices and pharmaceutical company

More

Latest News & Reports

Latest News

5

Johnson & Johnson Announces New Global Classification System for Surgical Outcomes

Johnson & Johnson introduced the peer-reviewed DISH Classification System to standardize the reporting of surgical outcomes such as infection and hematoma. This initiative aims to improve consistency across various surgical specialties.

Johnson & Johnson·August 24, 2026

Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit

Johnson & Johnson announced its participation in the upcoming Deutsche Bank 2026 Healthcare Summit. This event is part of the company's ongoing investor relations and industry engagement strategy.

Morningstar·September 2, 2026

Johnson & Johnson Publishes New Future of Digital Surgery Report to Help Define the Emerging Field of Surgical Intelligence

The company released a report outlining a framework for surgical intelligence, drawing on insights from healthcare and technology leaders. The document provides a foundation for the responsible operationalization of digital surgery.

Johnson & Johnson·August 18, 2026

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

The company has scheduled an investor conference call to discuss its financial performance for the third quarter of 2026. The event is set to provide insights into the company's recent operational results.

Johnson & Johnson Investor Relations·August 31, 2026

Johnson & Johnson Announces MONARCH™ QUEST 3, Advancing the Latest in Robotically-Assisted Bronchoscopy

Johnson & Johnson launched the MONARCH™ QUEST 3 software update for its robotic platform. The update is designed to improve navigation and targeting capabilities for the early detection of lung cancer.

Johnson & Johnson·August 17, 2026

Rate This

once per day
Your rating7

Rating Insights

No ratings yet. Be the first to rate this subject and start the trend.

Rating Over Time

No ratings in this period yet

Comments

0

Create a free account to share your thoughts

No comments yet. Be the first to share your thoughts!